Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 May;4(4):513-5.
doi: 10.4161/auto.5725. Epub 2008 Feb 13.

PERK-dependent regulation of MDA-7/IL-24-induced autophagy in primary human glioma cells

Affiliations

PERK-dependent regulation of MDA-7/IL-24-induced autophagy in primary human glioma cells

Margaret A Park et al. Autophagy. 2008 May.

Abstract

Melanoma differentiation associated gene-7/interleukin 24 (mda-7/IL-24) is a novel cytokine displaying selective apoptosis-inducing activity in transformed cells without harming normal cells. The studies by Yacoub et al. (Mol Cancer Ther 2008; 7:314-29) further defines the mechanism(s) by which a GST-MDA-7 fusion protein inhibits cell survival of primary human glioma cells in vitro. GST-MDA-7 killed glioma cells with diverse genetic characteristics that were dependent on activation of JNK1-3 with subsequent activation of BAX and the induction of mitochondrial dysfunction. Activation of JNK1-3 was dependent upon protein kinase R-like endoplasmic reticulum kinase (PERK) and GST-MDA-7 lethality was suppressed in PERK(-/-) cells. GST-MDA-7 caused PERK-dependent vacuolization of LC3-expressing endosomes whose formation was suppressed by incubation with 3-methyladenine, expression of HSP70 or of BiP/GRP78, or by knockdown of ATG5 or Beclin 1 expression, but not by inhibition of the JNK1-3 pathway. Knockdown of ATG5 or Beclin 1 expression or overexpression of HSP70 reduced GST-MDA-7 lethality. Our data demonstrate that GST-MDA-7 induces an ER stress response that, via the induction of autophagy, is causal in the activation of pro-apoptotic pathways that converge on the mitochondrion and ultimately culminate in decreased glioma cell survival.

PubMed Disclaimer

Figures

Figure 1
Figure 1
GST-MDA-7 causes PERK-dependent vacuolization and JNK pathway activation in transformed cells that leads to cell death. Exposure to GST-MDA-7 causes a PERK-dependent activation of the JNK pathway and a PERK-dependent inactivation of the ERK1/2 pathway. Enhanced JNK pathway signaling plays a key role in the activation of pro-caspase 2, pro-caspase 4 and cathepsin B. Activation of cathepsin B promotes the cleavage/activation of the BH3 domain protein BID. Elevated JNK pathway signaling also activates BAX. Inactivation of the ERK1/2 pathway facilitates activation of BAD and BIM. Thus GST-MDA-7, via PERK signaling, promotes increased activity of at least 4 BH3 domain proteins which all act to cause mitochondrial dysfunction and ultimately promote cell killing.

Similar articles

Cited by

References

    1. Robins HI, Chang S, Butowski N, Mehta M. Therapeutic advances for glioblastoma multiforme: current status and future prospects. Curr Oncol Rep. 2007;9:66–70. - PubMed
    1. Jiang H, Lin JJ, Su ZZ, Goldstein NI, Fisher PB. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene. 1995;11:2477–86. - PubMed
    1. Ekmekcioglu S, Ellerhorst J, Mhashilkar AM, et al. Downregulated melanoma differentiation associated gene (mda-7) expression in human melanomas. Int J Cancer. 2001;94:54–9. - PubMed
    1. Ellerhorst JA, Prieto VG, Ekmekcioglu S. Loss of MDA-7 expression with progression of melanoma. J Clin Oncol. 2002;20:1069–74. - PubMed
    1. Huang EY, Madireddi MT, Gopalkrishnan RV, et al. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Oncogene. 2001;20:7051–63. - PubMed

Publication types